
The Cancer Celebrities
Why I love Farrah Fawcett and hate Sheryl Crow
Why I love Farrah Fawcett and hate Sheryl Crow
Japan’s restaurants are taking COVID precautions to a whole new level.
It’s possible that a good deal of the difference in the shots’ performance can be summed up with a simple phrase: More is better.
With FDA authorization for a kid-size COVID vaccine pending, a pediatrician and infectious-disease expert weighs in on what’s next.
The field’s future lies in reclaiming parts of its past that it willingly abandoned.
The CDC indicated that it would move toward a hands-off stance: Booster-eligible people should stick with one brand, but may mix and match at will.
You might have fewer antibodies now. But they’re better than the ones you started with.
The pandemic has boosted interest in trauma books full of advice that isn’t particularly relevant to what most Americans are going through.
Different chemically than it was a decade ago, the drug is creating a wave of severe mental illness and worsening America’s homelessness problem.
Hospital staff say they're facing a violence crisis.
We know more than ever about how to use boosters, but still very little about when to use them.
America has a choice to make.
Actually, you’re probably not in quarantine.
The drug, molnupiravir, is named after Thor’s hammer, Mjölnir. But its power depends on reaching the right people, in the right time frame.
For months we’ve been fixated on the idea that some people are at “high risk” and others aren’t. Now scientists have a better understanding of the continuum.
The phrase took off earlier this year but flew too close to the sun. Maybe we should let it burn.
It’s long past time for an upgrade.
A decision to go with a lower dose might have helped speed things up last year. Now we may be seeing the consequences.
This one is far from over, but the window to prepare for future threats is closing fast.
Pfizer’s CEO set a timeline for when Americans can expect the earliest news about shots for young children.